middl
east
respiratori
syndrom
coronaviru
merscov
emerg
zoonot
pathogen
broad
host
rang
extent
merscov
natur
trace
adapt
cell
entri
step
viru
bind
hostcel
carbohydr
well
proteinac
receptor
follow
receptor
interact
viru
util
divers
host
proteas
cleavag
activ
virushost
cell
membran
fusion
subsequ
genom
deliveri
fusion
genom
deliveri
step
complet
variabl
time
place
either
near
cell
surfac
deep
within
endosom
investig
focus
cov
develop
sever
methodolog
effect
distinguish
differ
cell
entri
pathway
describ
method
highlight
viruscel
entri
factor
entri
inhibitor
viral
determin
specifi
cell
entri
rout
specif
method
describ
herein
util
reveal
merscov
entri
pathway
equal
suit
cov
well
proteasedepend
viral
speci
middl
east
respiratori
syndrom
coronaviru
merscov
endem
bat
also
dromedari
camel
transmit
zoonot
camel
human
viru
discov
human
sinc
laboratoryconfirm
case
worldwid
infect
human
suffer
fatal
outcom
although
merscov
zoonot
humantohuman
transmiss
rate
declin
due
gener
awar
improv
hospit
practic
continu
possibl
epidem
need
prevent
vaccin
therapeut
antivir
mechanist
insight
human
merscov
entri
promot
vaccin
antivir
drug
develop
merscov
like
coronavirus
exist
envelop
extracellular
particl
protrud
spike
protein
infect
initi
viral
protein
bind
host
cell
receptor
subsequ
proteolyt
cleavag
cellbound
protein
trigger
proteinmedi
coalesc
fusion
viral
cell
membran
trigger
process
involv
seri
current
obscur
protein
conform
chang
prefus
metast
state
extend
fusion
intermedi
postfus
collaps
state
exist
viru
cell
membran
coalesc
viral
mrna
genom
dispens
host
cell
cytoplasm
event
depend
cellular
proteas
one
may
expect
avail
particular
proteas
immedi
follow
receptor
engag
ratelimit
step
cov
entri
cellular
proteas
accumul
distinct
subcellular
locat
endocyt
cov
entri
pathway
serin
proteas
trypsin
elastas
extracellular
type
ii
transmembran
serin
proteas
ttsp
anchor
plasma
membran
cysteinetyp
cathepsin
proteas
enrich
endosom
sever
cov
infect
proteas
requir
howev
possibl
distinct
potenti
activ
fusion
product
infect
ensu
evid
particular
cov
prefer
vivo
entri
rout
eg
merscov
prefer
plasma
membran
entri
mhvcov
prefer
endosom
entri
see
fig
knowledg
prefer
rout
relat
virusinduc
diseas
necessari
identifi
viru
variant
might
high
transmiss
diseas
potenti
recogn
host
factor
might
target
therapeut
infect
suppress
cell
entri
stage
provid
protocol
dissect
cov
entri
pathway
includ
procedur
pseudoviru
product
particl
purif
concentr
well
specif
assay
differenti
cov
entri
pathway
protocol
set
character
merscov
entri
readili
adjust
evalu
cov
proteasedepend
viru
entri
event
lglut
gl
glucos
mm
sodium
pyruv
addit
supplement
includ
fetal
bovin
serum
mm
hepe
mm
nonessenti
amino
acid
uml
penicillin
g
streptomycin
transfect
media
dmem
lglut
gl
glucos
mm
sodium
pyruv
fetal
bovin
serum
serumfre
media
dmem
lglut
gl
glucos
mm
sodium
pyruv
addit
supplement
includ
mm
hepe
mm
nonessenti
amino
acid
uml
penicillin
g
streptomycin
polyethylenimin
pei
mgml
dissolv
optimem
reduc
serum
medium
express
plasmid
merscovspik
express
plasmid
hiv
corefluc
transduc
particl
pseudotyp
junin
viru
junv
gp
purif
concentr
vehicl
control
dmso
serumfre
media
equival
level
proteas
inhibitor
cocktail
cov
fusion
antagonist
cov
speciesmatch
peptid
express
plasmid
carri
incub
c
co
unless
otherwis
specifi
product
see
note
plate
enough
cell
ml
cm
dish
reach
confluenc
next
day
follow
day
make
transfect
mixtur
ad
merscovspik
plasmid
see
note
pei
ml
optimem
incub
mixtur
dark
min
room
temperatur
replac
exist
media
ml
transfect
media
prewarm
c
see
note
add
transfect
mixtur
dropwis
onto
cell
incub
cell
h
see
note
replac
transfect
media
ml
cell
media
incub
overnight
dilut
transduc
particl
pseudotyp
junin
viru
junv
gp
see
note
ml
prewarm
serumfre
media
use
replac
exist
media
transfect
cell
incub
cell
h
remov
supernat
rins
cell
ml
prewarm
serumfre
media
three
time
add
back
ml
prewarm
cell
media
incub
cell
overnight
collect
supernat
first
collect
ml
falcon
tube
add
back
ml
prewarm
cell
media
incub
cell
overnight
see
note
spin
supernat
g
min
c
transfer
supernat
fresh
tube
spin
g
min
c
discard
pellet
transfer
supernat
fresh
tube
freez
c
follow
day
repeat
step
second
collect
final
day
collect
supernat
third
collect
discard
cell
repeat
step
spin
supernat
g
min
c
transfer
supernat
fresh
tube
spin
g
min
c
discard
pellet
transfer
supernat
fresh
tube
freez
c
follow
day
repeat
step
second
collect
final
day
collect
supernat
third
collect
discard
cell
repeat
step
note
pseudovirus
lose
transduct
capabl
upon
exposur
high
gforc
g
commonli
use
tradit
viral
concentr
method
therefor
adopt
lowspe
viral
concentr
purif
protocol
achiev
viral
concentr
without
compromis
viral
transduct
capabl
thaw
pool
collect
pseudoviruscontain
supernat
see
subhead
transfer
ml
pool
supernat
ultraclear
tube
use
ml
syring
needl
add
cushion
ml
sucros
bottom
tube
eject
syring
slowli
avoid
sucros
mix
sampl
placement
cushion
gentli
add
remain
sampl
ml
tube
still
space
add
serumfre
media
brim
ultraclear
tube
load
ultraclear
tube
bucket
spin
rpm
g
h
c
spin
care
take
ultraclear
tube
remov
supernat
without
disturb
pellet
bottom
center
may
invis
quickli
add
back
ml
serumfre
media
gentli
resuspend
pellet
ml
pipett
see
note
aliquot
store
fulli
resuspend
sampl
purifi
c
futur
use
subsequ
receptor
engag
cov
spike
requir
proteolyt
cleavag
trigger
membran
fusion
two
class
cellular
proteas
identifi
trigger
cov
fusion
serin
proteas
either
secret
express
plasma
membran
cystein
proteas
resid
endosom
therefor
util
specif
proteas
given
cov
also
dictat
site
entri
util
sever
assay
differenti
prefer
site
entri
wildtyp
wt
mutant
mer
spike
efficaci
entri
inhibitor
identif
proor
antivir
host
factor
cov
site
entri
correl
entri
kinet
viral
entri
plasma
membran
earli
entri
endosom
late
relat
differ
viru
traffick
time
prior
membran
fusion
togeth
knowledg
cov
entri
requir
proteolysi
util
timecours
assay
character
cov
entri
kinet
proteas
inhibitor
ad
variou
time
point
arrest
futur
entri
allow
readout
infect
within
short
inocul
time
window
remov
media
add
lyse
cell
freez
plate
c
min
thaw
plate
transfer
white
read
plate
analyz
firefli
luciferas
activ
normal
enzym
activ
condit
vehicl
control
set
plot
data
viral
entri
protocol
describ
subhead
flexibl
tailor
evalu
differ
viral
inhibitor
includ
fusion
inhibitor
cov
spike
protein
facilit
membran
fusion
transit
extend
fusion
intermedi
postfus
conform
transit
requir
interact
antiparallel
helic
term
heptad
repeat
region
arrest
exogen
peptid
bind
fusion
intermedi
typic
peptid
enter
endosom
therefor
arrest
virus
transit
intermedi
conform
extracellularli
ie
target
cell
plasma
membran
howev
lipidconjug
peptid
bind
plasma
membran
endocytos
accumul
endosom
arrest
intracellular
viruscel
membran
fusion
use
modifi
subhead
test
efficaci
nativ
vs
lipidconjug
block
cov
endosom
entri
thaw
plate
transfer
white
read
plate
analyz
firefli
luciferas
activ
normal
enzym
activ
condit
vehicl
control
set
plot
data
viral
entri
current
protocol
describ
particl
product
diamet
plate
protocol
scale
long
ratio
compon
remain
constant
howev
consist
reproduc
recommend
produc
particl
contain
size
smaller
diamet
use
pei
transfect
reagent
use
dna
per
million
cell
cell
detach
plate
exert
care
replac
media
alway
add
back
media
aspir
soon
possibl
prevent
celldri
ad
media
liquid
land
side
wall
plate
directli
onto
cell
alway
prewarm
media
dna
pei
ratio
optim
specif
transfect
period
h
transfect
allow
go
overnight
lower
dna
pei
ratio
junv
pseudoviru
chosen
short
halflif
reduc
amount
inoculum
junv
gp
pseudoviru
contamin
desir
protocol
maxim
pseudoviru
product
take
three
consecut
harvest
produc
cell
indic
spin
speed
kfactor
sinc
sediment
coeffici
vsv
hiv
pseudoviru
around
spin
suffici
actual
spin
time
doubl
insur
pseudovirus
pellet
viscou
sucros
cushion
resuspend
pellet
set
ml
pipett
pipett
gentli
avoid
bubbl
make
sure
rins
entir
bottom
tube
maxim
collect
current
protocol
describ
viral
entri
cell
seed
plate
protocol
scale
long
ratio
compon
remain
constant
remov
media
via
aspir
return
fresh
media
cell
soon
possibl
prevent
cell
dri
aspir
return
media
maximum
well
time
cov
entri
kinet
uniqu
viru
host
cell
combin
cell
merscov
entri
complet
around
h
hela
cell
entri
take
hour
complet
pilot
experi
larger
time
interv
min
recommend
vehicl
control
proteas
inhibitor
dmso
cytotox
high
concentr
pilot
experi
recommend
identifi
nontox
dmso
concentr
sampl
kept
c
month
read
fluc
prevent
signal
loss
proteas
inhibitor
cocktail
ad
cclr
use
cell
type
kill
pei
dna
transfect
lipidbas
transfect
vector
lipofectamin
use
instead
cell
type
resist
transfect
retroor
lentiviralbas
adenovirusbas
transduct
system
use
introduc
gene
interest
